Logo Image
|Articles|December 3, 2020

WCG Acquires Trifecta

WCG announced its acquisition of Trifecta Clinical, including its site communication platform InvestigatorSpace, virtual training programs, and safety documentation services.

Dave Young, Trifecta’s Founder and CEO, said, “We’re thrilled to be joining WCG, a company that shares our passion for improving the clinical trial process by delivering impactful solutions to age-old problems. This acquisition was a natural evolution for Trifecta.”

Moving forward, Trifecta will be known as WCG Trifecta, and will retain its leadership structure, along with its headquarters in Los Angeles, and locations in Indianapolis, Philadelphia, and Osaka, Japan.

For the full release, click here.

Related to this article

View more
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
What "Patient Voice" Actually Requires: Beyond the Buzzword
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Read more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more